226 related articles for article (PubMed ID: 22710939)
41. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
42. Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells.
Beretta GL; Gatti L; Tinelli S; Corna E; Colangelo D; Zunino F; Perego P
Biochem Pharmacol; 2004 Jul; 68(2):283-91. PubMed ID: 15194000
[TBL] [Abstract][Full Text] [Related]
43. Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy.
Martinez-Balibrea E; Martínez-Cardús A; Musulén E; Ginés A; Manzano JL; Aranda E; Plasencia C; Neamati N; Abad A
Int J Cancer; 2009 Jun; 124(12):2905-10. PubMed ID: 19296535
[TBL] [Abstract][Full Text] [Related]
44. Silencing the Menkes copper-transporting ATPase (Atp7a) gene in rat intestinal epithelial (IEC-6) cells increases iron flux via transcriptional induction of ferroportin 1 (Fpn1).
Gulec S; Collins JF
J Nutr; 2014 Jan; 144(1):12-9. PubMed ID: 24174620
[TBL] [Abstract][Full Text] [Related]
45. Silencing of the Menkes copper-transporting ATPase (Atp7a) gene increases cyclin D1 protein expression and impairs proliferation of rat intestinal epithelial (IEC-6) cells.
Gulec S; Collins JF
J Trace Elem Med Biol; 2014 Oct; 28(4):459-64. PubMed ID: 25156967
[TBL] [Abstract][Full Text] [Related]
46. ATP7A transgenic and nontransgenic mice are resistant to high copper exposure.
Ke BX; Llanos RM; Mercer JF
J Nutr; 2008 Apr; 138(4):693-7. PubMed ID: 18356322
[TBL] [Abstract][Full Text] [Related]
47. Effects of the loss of Atox1 on the cellular pharmacology of cisplatin.
Safaei R; Maktabi MH; Blair BG; Larson CA; Howell SB
J Inorg Biochem; 2009 Mar; 103(3):333-41. PubMed ID: 19124158
[TBL] [Abstract][Full Text] [Related]
48. Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin.
Huang CP; Fofana M; Chan J; Chang CJ; Howell SB
Metallomics; 2014 Mar; 6(3):654-61. PubMed ID: 24522273
[TBL] [Abstract][Full Text] [Related]
49. [Structure and function of ATP7A and ATP7B proteins--Cu-transporting ATPases].
Lenartowicz M; Krzeptowski W
Postepy Biochem; 2010; 56(3):317-27. PubMed ID: 21117320
[TBL] [Abstract][Full Text] [Related]
50. Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells.
Katano K; Safaei R; Samimi G; Holzer A; Tomioka M; Goodman M; Howell SB
Clin Cancer Res; 2004 Jul; 10(13):4578-88. PubMed ID: 15240550
[TBL] [Abstract][Full Text] [Related]
51. Clusterin and COMMD1 independently regulate degradation of the mammalian copper ATPases ATP7A and ATP7B.
Materia S; Cater MA; Klomp LW; Mercer JF; La Fontaine S
J Biol Chem; 2012 Jan; 287(4):2485-99. PubMed ID: 22130675
[TBL] [Abstract][Full Text] [Related]
52. Mechanistic basis for overcoming platinum resistance using copper chelating agents.
Liang ZD; Long Y; Tsai WB; Fu S; Kurzrock R; Gagea-Iurascu M; Zhang F; Chen HH; Hennessy BT; Mills GB; Savaraj N; Kuo MT
Mol Cancer Ther; 2012 Nov; 11(11):2483-94. PubMed ID: 22914438
[TBL] [Abstract][Full Text] [Related]
53. Copper transporting P-type ATPases and human disease.
Cox DW; Moore SD
J Bioenerg Biomembr; 2002 Oct; 34(5):333-8. PubMed ID: 12539960
[TBL] [Abstract][Full Text] [Related]
54. Intracellular targeting of copper-transporting ATPase ATP7A in a normal and Atp7b-/- kidney.
Linz R; Barnes NL; Zimnicka AM; Kaplan JH; Eipper B; Lutsenko S
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F53-61. PubMed ID: 17928409
[TBL] [Abstract][Full Text] [Related]
55. Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs.
Petruzzelli R; Polishchuk RS
Cells; 2019 Sep; 8(9):. PubMed ID: 31540259
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
Ip V; Liu JJ; McKeage MJ
Clin Exp Pharmacol Physiol; 2013 Jun; 40(6):371-8. PubMed ID: 23556474
[TBL] [Abstract][Full Text] [Related]
57. The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin.
Safaei R; Adams PL; Maktabi MH; Mathews RA; Howell SB
J Inorg Biochem; 2012 May; 110():8-17. PubMed ID: 22459168
[TBL] [Abstract][Full Text] [Related]
58. COX19 mediates the transduction of a mitochondrial redox signal from SCO1 that regulates ATP7A-mediated cellular copper efflux.
Leary SC; Cobine PA; Nishimura T; Verdijk RM; de Krijger R; de Coo R; Tarnopolsky MA; Winge DR; Shoubridge EA
Mol Biol Cell; 2013 Mar; 24(6):683-91. PubMed ID: 23345593
[TBL] [Abstract][Full Text] [Related]
59. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
[TBL] [Abstract][Full Text] [Related]
60. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
